Lifeboat Foundation

As the COVID-19 cases continue to rise globally, the National Medical Products Administration of China has approved the first-ever antiviral medicine called Favilavir. This medicine is said to possibly treat the now-declared pandemic illness.

Over the weekend, Taizhou’s city government announced that Favilavir, which was initially formulated by a Chinese-owned pharmaceutical firm, is the first medicine authorized to stop the widespread of this fatal illness. At present, this drug is being promoted with the label, Avigan.

Continue reading “‘Favilavir’: First Approved Drug to Possibly Treat Coronavirus” »

By Bill D’Zio

Soyuz creeping up in cost

NASA has been dependent on Russia for transport to and from the ISS. Over time the cost of seats on the Soyuz crew vehicle have risen.

The Roscosmos’s Soyuz vehicle has been ferrying crew to the International Space Station since November 2000. Originally Soyuz was designed to carry cosmonauts to the Moon, however was repurposed to be the main transport vehicle for Russia over the years. The Soyuz spacecraft is capable of carrying three crewmembers at a time and is certified to remain docked with the ISS for a maximum of 200 days and is launched from the Baikonur Cosmodrome launch site.

Until the NASA Commercial Crew Program (CCP) is completed, Roscosmos remains the sole option for transporting astronauts to and from the ISS. At all times, at least one of the Soyuz spacecraft is docked at the International Space Station serving as an emergency lifeboat or escape pot should evacuation be needed. Typically two Soyuz capsules are docked at the ISS which allows up to six astronauts to remain on the International Space Station. The limit of six astronauts is established by the number of seats available for evacuation.

Read the rest of the article.

The super-charged face scanning tech is costing the military at least $4.3 million.

The United States Army is currently building a super-charged facial recognition system — tech that could be ready for action as soon as next year.

The system, as described in a new One Zero story, analyzes infrared images of a person’s face to see if they’re a match for anyone on a government watchlist, such as a known terrorist. Not only will the finished system reportedly work in the dark, through car windshields, and even in less-than-clear weather conditions — but it’ll also be able to ID individuals from up to 500 meters away.

Continue reading “Army Developing Tech to ID Terrorists in the Dark From .5 KM Away” »

As they increasingly log on from home, Americans are having to meld their personal technology with professional tools at unprecedented scale. For employers, the concern isn’t just about capacity, but also about workers introducing new potential vulnerabilities into their routine — whether that’s weak passwords on personal computers, poorly secured home WiFi routers, or a family member’s device passing along a computer virus.

The dramatic expansion of teleworking by US schools, businesses and government agencies in response to the coronavirus is raising fresh questions about the capacity and security of the tools many Americans use to connect to vital workplace systems and data.

At one major US agency, some officials have resorted to holding meetings on iPhone group calls because the regular conference bridges haven’t always been working, according to one federal employee. But the workaround has its limits: The group calls support only five participants at a time, the employee noted.

Continue reading “Millions of Americans are suddenly working from home. That’s a huge security risk” »

Possible treatments for coronavirus:

Remdesivir by the firm Gilead was developed to fight other viruses including Ebola (where it was shown to be ineffective) and it hasn’t yet been approved for treating anything. Still, it has shown early promise in treating some coronavirus patients in China, according to doctors, and manufacturer Gilead is moving ahead with final stage clinical trials in Asia. It has also been used to treat at least one US patient so far.

NIH’s Anthony Fauci, one of the top government scientists overseeing the coronavirus response, has said it could be available in the next “several months.”

Continue reading “Over 20 vaccines, multiple treatments currently in development for coronavirus” »

“The Justice Department has quietly asked Congress for the ability to ask chief judges to detain people indefinitely without trial during emergencies — part of a push for new powers that comes as the coronavirus spreads through the United States.”

Coronavirus

One of the requests to Congress would allow the department to petition a judge to indefinitely detain someone during an emergency.

Responses to outbreak also show how government policy and behavioural changes can have impact.

ZURICH (Reuters) — Switzerland’s health care system could collapse by the end of the month if the new coronavirus keeps spreading at current rates, a government official warned on Tuesday.

Swiss authorities estimated that 2,650 people had tested positive for the coronavirus and said 19 people had died, while predicting cases will likely soar in the weeks ahead.

Exact figures were unavailable. Daniel Koch, head of the Federal Office of Health’s communicable diseases division, said the rapid rise had outstripped the state’s ability to record new cases in real time.

Sam Harris discusses the coronavirus withAmesh Adalja.

In this episode of the podcast, Sam Harris speaks with Amesh Adalja about the spreading coronavirus pandemic. They discuss the contagiousness of the virus and the severity of the resultant illness, the mortality rate and risk factors, vectors of transmission, how long coronavirus can live on surfaces, the importance of social distancing, possible anti-viral treatments, the timeline for a vaccine, the importance of pandemic preparedness, and other topics.

Continue reading “Making Sense with Sam Harris #191 — Early Thoughts On a Pandemic (with Amesh Adalja)” »